1. Coronavirus Vaccine: NYU's Dr. Robyn Gershon talks COVID-19 vaccine concerns  Yahoo Finance
  2. 1 in 7 Russian Coronavirus Vaccine Volunteers Report Side Effects  The Moscow Times
  3. Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine Development  Motley Fool
  4. Coronavirus vaccine: Americans could get COVID-19 vaccine by end of 2020: Pfizer CEO  Yahoo Finance
  5. Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven'  Sputnik International
  6. View Full coverage on Google News
Germany awarded $745 million in funding to biotech firms BioNTech and CureVac on Tuesday to speed up work on COVID-19 vaccines and expand German production capacity.Germany awarded $745 million in funding to biotech firms BioNTech and CureVac on Tuesday to speed up work on COVID-19 vaccines and expand German production capacity.

Germany grants BioNTech, CureVac $745 million to speed up COVID-19 vaccine work | Reuters

BioNTech SE shares undefined soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in...BioNTech SE shares undefined soared 4% in premarket trade Tuesday, after the drug company said it will receive up to 375 million euros ($445.9 million) in...

BioNTech shares jump premarket on news of 375 million euros in German funding for COVID-19 vaccine - MarketWatch

On Monday, Pfizer began a two-day investor presentation to show how it will become a growth stock.On Monday, Pfizer began a two-day investor presentation to show how it will become a growth stock.

Pfizer Highlights Dozens of Drugs in Its Pipeline. Here’s What It Means for the Stock. | Barron's

Albert Bourla, the CEO of Pfizer, said on Sunday morning that his company's trial of 30,000 people given a COVID vaccination was progressing well and he was optimistic.Albert Bourla, the CEO of Pfizer, said on Sunday morning that his company's trial of 30,000 people given a COVID vaccination was progressing well and he was optimistic.

Pfizer CEO says they could know if coronavirus vaccine works by the end of October | Daily Mail Online

BioNTech and CureVac will use the new funding to advance COVID-19 research and development in Germany.BioNTech and CureVac will use the new funding to advance COVID-19 research and development in Germany.

Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine Development | The Motley Fool

“The complications are described in the instructions and are predictable,” Russia's health minister said.“The complications are described in the instructions and are predictable,” Russia's health minister said.

1 in 7 Russian Coronavirus Vaccine Volunteers Report Side Effects - The Moscow Times

Germany boosts own vaccine makers in race for COVID-19 jabGermany boosts own vaccine makers in race for COVID-19 jab

Germany boosts own vaccine makers in race for COVID-19 jab | Taiwan News

Approval of a vaccine, however, will depend on federal regulators, Albert Bourla said.

Pfizer CEO says company will know if vaccine works by end of October

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.

Fifteen scientists launch critique of Russia’s COVID-19 vaccine data – EURACTIV.com

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

Bloomberg - Are you a robot?

Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Murashko said on Tuesday. "Over 300 persons have been vaccinated.

Over 300 Volunteers Get Russian COVID-19 Vaccine - Novinite.com - Sofia News Agency

egypttoday,Politics,Business,Economy,Art,culture,Local news,Special interest,Press Review,News,ResourcesHead of the Russian Direct Investment Fund Kirill Dmitriev said Tuesday that Egypt is one of Russia’s main partners in the region.

Egypt to be gate for "Sputnik V" vaccine to Africa: Russian official - Egypt Today

The world needs a vaccine against COVID-19, and with some 200 vaccine candidates in various stages of development, and more than 30 of these vaccines already in Phase 3 clinical trials, odds are we will get a vaccine -- probably several -- sooner than you might expect. J.P. Morgan analyst Cory KasimovThe world needs a vaccine against COVID-19, and with some 200 vaccine candidates in various stages of development, and more than 30 of these vaccines already in Phase 3 clinical trials, odds are we will get a vaccine -- probably several -- sooner than you might expect. J.P. Morgan analyst Cory Kasimov

Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine

Upping the phase 3 investigational vaccine trial size to 44,000 participants will also allow for the enrollment of new populations.Upping the phase 3 investigational vaccine trial size to 44,000 participants will also allow for the enrollment of new populations.

Pfizer Phase 3 Coronavirus Vaccine Data Slated For October

About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.

14% of volunteers testing pioneering Russian Covid-19 vaccine ‘Sputnik V’ have experienced side effects, health ministry says — RT Russia & Former Soviet Union

Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Saturday they are seeking the United States Food and Drug Administration ...Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Saturday they are seeking the United States Food and Drug Administration approval to expand the late-...

Pfizer, Inc. (NYSE:PFE), Astrazeneca PLC (NYSE:AZN) - Pfizer Seeks FDA Nod To Expand Late-Stage COVID-19 Vaccine Trial | Benzinga

Germany aims to reach herd immunity through a voluntary coronavirus vaccine expected to be widely available by mid-2021, the health minister said Tuesday.Germany aims to reach herd immunity through a voluntary coronavirus vaccine expected to be widely available by mid-2021, the health minister said Tuesday.

Germany eyes voluntary COVID-19 vaccine by mid-2021 | CTV News

The estimate is in line with a recent assessment from the World Health Organization.Minister Anja Karliczek said the German govt was offering around $890 mn in funding to help three domestic firms with their vaccine research and developmentThe estimate is in line with a recent assessment from the World Health Organization.Minister Anja Karliczek said the German govt was offering around $890 mn in funding to help three domestic firms with their vaccine research and development

'No risky shortcuts': Germany eyes Covid-19 vaccine by mid-2021

404 Not Found

We aren’t just Public Radio, we are The Public’s Radio. Hear us on WNPN 89.3FM across Rhode Island and the Southcoast of Massachusetts.

RIPR : The Public's Radio : RIPR

The official letter on the coronavirus vaccine came days after a larger group of scientists - including the 15 - signed an open letter to the Lancet's editor.The official letter on the coronavirus vaccine came days after a larger group of scientists - including the 15 - signed an open letter to the Lancet's editor.

Coronavirus vaccine update: 15 scientists voice concern over Russia’s Sputnik-V

Pfizer and BioNTech’s vaccine is one of 35 potential inoculations currently in some phase of clinical testing, according to the WHO.Pfizer and BioNTech’s vaccine is one of 35 potential inoculations currently in some phase of clinical testing, according to the WHO.

Pfizer could have a vaccine ready by end of the year, says CEO Albert Bourla

Pfizer CEO Albert Bourla to CBS: Will know coronavirus vaccine status by OctoberAlbert Bourla, the head of pharmaceutical giant Pfizer, which is among the companies developing a coronavirus vaccine, said that there is a 'good chance' the company will know whether its vaccine works by the end of October.

Pfizer CEO Albert Bourla to CBS: Will know coronavirus vaccine status by October | World News – India TV

Pfizer’s CEO says the pharmaceutical giant should know how effective its experimental COVID-19 vaccine will be by the end of October.Pfizer’s CEO says the pharmaceutical giant should know how effective its experimental COVID-19 vaccine will be by the end of October.

Pfizer CEO expects vaccine trial results before November | WOODTV.com

In a weekend interview on CBS’ “Face the Nation,” Albert Bourla, chief executive officer of Pfizer indicated they may have key data from its Phase III trial of the vaccine to the U.S. Food and Drug Administration by the end of October. In a weekend interview on CBS’ “Face the Nation,” Albert Bourla, chief executive officer of Pfizer indicated they may have key data from its Phase III trial of the vaccine to the U.S. Food and Drug Administration by the end of October.

Pfizer, BioNTech Say COVID-19 Vaccine Might Be Ready by End of October | BioSpace

The German government says a vaccine for coronavirus would not be available globally before the middle of 2021. Research Minister Anja Karliczek said thisThe German government says a vaccine for coronavirus would not be available globally before the middle of 2021. Research Minister Anja Karliczek said this

Germany hints when COVID-19 vaccine will be available globally - Daily Post Nigeria

Pfizer's RNA-based Covid-19 vaccine candidate BNT162b2 which is being developed in partnership with BioNTech is set to enter Phase 3 human trials.

Coronavirus USA: When could Pfizer's vaccine start shipping? - AS.com

Germany will not take risky shortcuts when developing a vaccine against COVID-19, Research Minister Anja Karliczek said on Tuesday.Germany will not take risky shortcuts when developing a vaccine against COVID-19, Research Minister Anja Karliczek said on Tuesday.

Germany won't take risky short-cuts on COVID-19 vaccines—minister | Inquirer News

Russia has recruited sufficient participants for its large-scale Covid-19 vaccine trial, known as a Phase III trial, the head of Russia's sovereign wealth fund, which is backing the vaccine said.Russia has recruited sufficient participants for its large-scale Covid-19 vaccine trial, known as a Phase III trial, the head of Russia's sovereign wealth fund, which is backing the vaccine said.

Russia completes volunteer recruitment for Covid-19 vaccine trial - fund | News24

MILAN, Sept 15 — A group of scientists sent a formal letter to the Lancet yesterday outlining doubts about the accuracy of early data on Russia's Covid-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the “Sputnik-V” shot. Fifteen scientists from five...MILAN, Sept 15 — A group of scientists sent a formal letter to the Lancet yesterday outlining doubts about the accuracy of early data on Russia's Covid-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the “Sputnik-V” shot. Fifteen scientists from five...

15 scientists launch critique of Russia's Covid-19 vaccine data | World | Malay Mail

Pfizer Inc.’s $48 billion gain in market value since late March, egged on by optimism for a successful Covid-19 vaccine, may soon hit a wall.

Pfizer poised for drop after US$48B climb on COVID vaccine - BNN Bloomberg

NEW YORK (REUTERS) - Pfizer Inc said on Monday (Sept 14) that it had enrolled more than 29,000 people in its 44,000-volunteer trial to test the experimental Covid-19 vaccine it is developing with German partner BioNTech.. Read more at straitstimes.com.United States News -NEW YORK (REUTERS) - Pfizer Inc said on Monday (Sept 14) that it had enrolled more than 29,000 people in its 44,000-volunteer trial to test the experimental Covid-19 vaccine it is

Pfizer says enrolled more than 29,000 people in its Covid-19 vaccine trial, United States News & Top Stories - The Straits Times

Russian Public Health watchdog, Rospotrebnadzor, on Tuesday stated that no less than 26 different vaccines against coronavirus were currently being developed in the country. Anna Popova, head of the Rospotrebnadzor, said in August, Sputnik V, developed by Russia’s Gamaleya National Research Centre of Epidemiology and Microbiology and the Russian Direct Investment Fund, became world’s firstRead More

Russia claims 26 COVID-19 vaccines under development - Vanguard News

Fox News medical contributor Dr. Marc Siegel said Monday that the common flu, unlike coronavirus, is a "moving target" that often changes form from year to year, while COVID is more static in that regard.Fox News medical contributor Dr. Marc Siegel said Monday that the common flu, unlike coronavirus, is a "moving target" that often changes form from year to year, while COVID is more static in that regard.

GROTON, CT (WFSB) - The race to find a COVID-19 vaccine continues.GROTON, CT (WFSB) - The race to find a COVID-19 vaccine continues.

Pfizer aims to learn if its COVID-19 vaccine works by the end of October | News | wfsb.com

The German government announced Tuesday it would provide up to 750 million euros ($892 million) to support three domestic pharmaceutical companies developing vaccines for COVID-19.The German government announced Tuesday it would provide up to 750 million euros ($892 million) to support three domestic pharmaceutical companies developing vaccines for COVID-19.

Berlin pumping hundreds of millions of euros into German COVID-19 vaccine developers | TheHill

The German government announced Tuesday it would provide up to 750 million euros ($892 million) to support three domestic pharmaceutical companies developing vaccines for COVID-19.The German government announced Tuesday it would provide up to 750 million euros ($892 million) to support three domestic pharmaceutical companies developing vaccines for COVID-19.

Berlin pumping hundreds of millions of euros into German COVID-19 vaccine developers | TheHill

Pfizer CEO, Albert Boula, has said the drug company could release a coronavirus vaccine before the year is out if approved by the FDA.Pfizer CEO, Albert Boula, has said the drug company could release a coronavirus vaccine before the year is out if approved by the FDA.

Pfizer could have working Covid-19 vaccine before the end of 2020 | Buzz.ie

BERLIN: German biotech firm BioNTech said on Tuesday (Sep 15) it had secured almost US$450 million in government funding to speed up work on its ...BERLIN: German biotech firm BioNTech said on Tuesday (Sep 15) it had secured almost US$450 million in government funding to speed up work on its ...

BioNTech wins US$445 million German grant for COVID-19 vaccine - CNA

Pfizer is among the stocks driving the rally in US futures after CEO's optimistic announcement over vaccine.Pfizer is among the stocks driving the rally in US futures after CEO's optimistic announcement over vaccine.

Pfizer stock rockets as potential COVID-19 vaccine delivery by end of 2020

Last week, a group of Russian scientists published the results of two phase 1/2 vaccine trials for a new Covid-19 vaccine. Soon after the paper appeared, other scientists raised serious questions about the integrity of the data.Last week, a group of Russian scientists published the results of two phase 1/2 vaccine trials for a new Covid-19 vaccine. Soon after the paper appeared, other scientists raised serious questions about the integrity of the data.

Did The Russians Fabricate Data About Their Covid-19 Vaccine Trial?

Drugmaker Pfizer could know before the November election whether its coronavirus vaccine is safe and effective.Drugmaker Pfizer could know before the November election whether its coronavirus vaccine is safe and effective.

Pfizer COVID-19 vaccine may be ready for approval by October, CEO says

Pharmaceutical giant Pfizer will likely know by the end of next month if its coronavirus vaccine is effective, CEO Albert Bourla said.Pharmaceutical giant Pfizer will likely know by the end of next month if its coronavirus vaccine is effective, CEO Albert Bourla said.

Pfizer should know if COVID vaccine works by end of October

Pfizer CEO announced that the company's COVID-19 vaccine may be ready by the year-end if things go well while adding that it is already being mass-produced.Pfizer CEO announced that the company's COVID-19 vaccine may be ready by the year-end if things go well while adding that it is already being mass-produced.

COVID-19 vaccine manufacturing has begun at a risk, will be ready by year-end: Pfizer CEO - Republic World